Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up
- PMID: 3674851
- PMCID: PMC174961
- DOI: 10.1128/AAC.31.9.1442
Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up
Abstract
Women with recurrent urinary tract infections treated with cefuroxime axetil (500 or 250 mg twice daily) for 7 days had a higher relapse rate when tested 6 weeks after the start of treatment than those given amoxycillin (250 mg three times daily). The poor performance of cefuroxime axetil is explained by variable bioavailability.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
